Mounjaro

Active Ingredient(s): Tirzepatide
FDA Approved: * May 13, 2022
Pharm Company: * ELI LILLY CO
Category: Diabetes
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Mounjaro 15 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1457
Labeler:
Eli Lilly and Company
Mounjaro 12.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1460
Labeler:
Eli Lilly and Company
Mounjaro 10 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1471
Labeler:
Eli Lilly and Company
Mounjaro 7.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1484
Labeler:
Eli Lilly and Company
Mounjaro 5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1495
Labeler:
Eli Lilly and Company
Mounjaro 2.5 mg/.5ml Subcutaneous Injection, Solution
NDC: 0002-1506
Labeler:
Eli Lilly and Company